ImmuCell Corporation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount
ImmuCell Corporation (ICCC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount of -$42.66 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-25.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2016-03-25
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, research and development, amount for fiscal 2015 was -$42.66K.
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, research and development, amount for fiscal 2014 was -$19.41K.
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, research and development, amount for fiscal 2013 was -$21.89K.
- ImmuCell Corporation effective income tax rate reconciliation, nondeductible expense, research and development, amount for fiscal 2012 was -$10.81K, a 145.44% decline from fiscal 2011.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount 12 month as first filed |
|---|---|---|
| 2015-12-31 | -$42.66K 10-K · filed 2016-03-25 | |
| 2014-12-31 | -$19.41K 10-K · filed 2016-03-25 | |
| 2013-12-31 | -$21.89K 10-K · filed 2016-03-25 | $21.89K 10-K · filed 2014-03-26 |
| 2012-12-31 | -$10.81K 10-K · filed 2015-03-26 | |
| 2011-12-31 | $23.80K 10-K · filed 2014-03-26 | -$23.80K 10-K · filed 2013-03-28 |
| 2010-12-31 | -$22.36K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |